Showing results (11-20 of 218) with videos related to
Sort By:
Pageof 22
Leukemia Research|August 4, 2009
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 YearsStefan Faderl, William Wierda, Susan O'Brien, et al.Hematology/Oncology and Stem Cell Therapy|June 29, 2016
Membranoproliferative glomerulonephritis and acute renal failure in a patient with chronic lymphocytic leukemia: Response to obinutuzumabPunit Jain, Rashmi Kanagal-Shamanna, William Wierda, et al.Cancer|July 29, 2009
A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemiaNitin Jain, William Wierda, Alessandra Ferrajoli, et al.Current Hematologic Malignancy Reports|December 11, 2012
CARs in chronic lymphocytic leukemia -- ready to driveChitra Hosing, Partow Kebriaei, William Wierda, et al.Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspectiveNina Shah, Katy Rezvani, Chitra Hosing, et al.Leukemia & Lymphoma|July 2, 2013
Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemiaPaolo Strati, Alessandra Ferrajoli, Susan Lerner, et al.International Journal of Molecular Sciences|March 29, 2023
Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic LeukemiaTi'ara L Griffen, Fieke W Hoff, Yihua Qiu, et al.Cancer|December 6, 2011
The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemiaRavin Garg, William Wierda, Alessandra Ferrajoli, et al.Acta Crystallographica Section B, Structural Science, Crystal Engineering and Materials|August 25, 2020
The incommensurately modulated structures of low-temperature labradorite feldspars: a single-crystal X-ray and neutron diffraction studyShiyun Jin, Huifang Xu, Xiaoping Wang, et al.Cancer|August 15, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaPaolo Strati, William Wierda, Jan Burger, et al.Pageof 22